Medicure (MCUJF) Gross Margin (2009 - 2026)

Medicure (MCUJF) recorded quarterly Gross Margin of 44.31% in Q1 2026, up 40.34% quarter-over-quarter from 31.57% in Q4 2025, and down 754.0% on a YoY basis from 6.77% in Q1 2025.

Medicure (MCUJF) Gross Margin (2009 - 2026) Analysis & Trends

Medicure's Gross Margin history runs 18 years deep, the most recent figure standing at 44.31% for Q1 2026.

  • In Q1 2026, Gross Margin fell 754.0% year-over-year to 44.31%; the TTM figure through Mar 2026 stood at 39.69% (down 1580.0% YoY), while the FY2025 annual figure was 40.71%, down 1903.0% from the prior year.
  • Gross Margin was 44.31% for Q1 2026 at Medicure, up from 31.57% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 73.69% in Q3 2022 to a low of 31.57% in Q4 2025.
  • Historically, Gross Margin has averaged 57.46% across 5 years, with a median of 58.37% in 2024.
  • The sharpest annual moves came in 2022 and 2025: Gross Margin surged 5440 bps in 2022, then slumped 2680 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 69.03% in 2022, then retreated by 0 bps to 69.03% in 2023, then dropped by 15 bps to 58.37% in 2024, then slumped by 46 bps to 31.57% in 2025, then surged by 40 bps to 44.31% in 2026.
  • The last three Gross Margin figures came in at 44.31% (Q1 2026), 31.57% (Q4 2025), and 33.99% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 49.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 71.66%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.26%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -293.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 65.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 61.20%
10 Medicure - - 2.57 Mn 44.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 44.31%
Dec 31, 2025 31.57%
Sep 30, 2025 33.99%
Jun 30, 2025 51.51%
Mar 31, 2025 51.84%
Dec 31, 2024 58.37%
Sep 30, 2024 54.32%
Jun 30, 2024 57.15%
Mar 31, 2024 68.44%
Dec 31, 2023 69.03%
Sep 30, 2023 72.77%
Jun 30, 2023 69.88%
Mar 31, 2023 67.45%
Dec 31, 2022 69.03%
Sep 30, 2022 73.69%
Jun 30, 2022 33.11%
Mar 31, 2022 70.42%
Sep 30, 2021 19.29%
Jun 30, 2021 59.75%
Mar 31, 2021 60.96%